treatment with Xywav. In the clinical trial for IH, the most consistent with prescribing information AND the patient does not
(Xywav). These agents have Black Box Warnings. and are subject to prescribing information have been completed as of the date of the request and will.
XYWAV and XYREM properly, how to store them safely, and how to get XYWAV and XYREM. It also gives important information about the risks associated with XYWAV and XYREM. The REMS Prescriber Enrollment Form, Patient Enrollment Form, and XYWAV Prescription Form or XYREM Prescription Form must be completed in full and sent to the XYWAV and XYREM REMS.
34. PA requests for Xywav must include detailed clinical justification for prescribing Xywav instead of Xyrem. This clinical information must document why
LUMRYZ (sodium oxybate for extended-release oral suspension). Prescribing Information. Chesterfield, MO: Avadel Pharmaceuticals. 2. XYWAV. Prescribing
Xywav, a Schedule III controlled substance, carries a Boxed Prescribing information. Pfizer; 2024. Accessed Septem
Information. N/A. Age Restrictions N/A. Prescriber. Restrictions. PAH and CTEPH Concomitant use with Xywav, Wakix or Sunosi. Required. Medical. Information.
Please review the Prescribing Information for XYWAV and XYREM. XYWAV and XYREM may be dispensed only to patients enrolled in the XYWAV and XYREM REMS. XYWAV is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy
Xywav Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; July 2024. Available at:
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.